HEALTH

Target’s Made to Matter program to feature Zarbee’s Naturals new baby supplement line

BY Michael Johnsen

 

 
 
SALT LAKE CITY — Zarbee's Naturals on Tuesday introduced a Target-exclusive line of natural baby vitamins and supplements for infants and toddlers. 
 
"We're proud to introduce a new line of vitamins and supplements that provide a full range of wellness solutions for moms with infants and toddlers," said Bret Furio, CEO Zarbee's Naturals. "We're also pleased to share that this new line has been selected by Target to be a part of their 2015 Made to Matter collection of leading natural, organic and sustainable brands."
 
Zarbee's line of new baby vitamins and supplements are pediatrician recommended and contain natural ingredients such as agave and coconut oil to provide safe and effective solutions for growing babies. The line features probiotic Lcr35, which helps restore and maintain balance in your baby's digestive system. The products are gluten-free, dye­free and contain no drugs or alcohol.
 
The new line includes:
 
  • Baby Probiotic Supplement: Zarbee's Baby Probiotic supplement promotes and maintains intestinal health by restoring the natural balance in the baby's digestive tract. The proprietary 3Biotic formula contains a prebiotic, probiotic and natural postbiotic to increase delivery of this beneficial bacteria to the child's digestive system;
  • Baby Vitamin D Supplement: This supplement delivers vitamin D in a natural coconut oil to help absorb calcium for strong bones and teeth. The American Academy of Pediatrics recommends supplementing a breastfed infant with 400 IUs of vitamin D daily since an adequate amount of vitamin D is not transferred through breast milk;
  • Baby Omega-3: Zarbee's Omega-3 DHA supplement is formulated with plant-based DHA and natural coconut oil. Adequate intake of DHA has been shown to support brain, eye and nervous system development during all stages of life; and
  • Baby Multi Vitamin with Iron Supplement: This multivitamin is specially designed to meet the needs of a growing infant and toddler. It delivers 100% of the daily recommended value for infants of nine essential vitamins including vitamins A, C and D as well as iron.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Nutramax to form expert panel to improve G/C guidelines

BY Michael Johnsen

EDGEWOOD, Md. — Nutramax Laboratories Consumer Care on Tuesday announced plans to assemble a panel of joint health experts to review current American Academy of Orthopaedic Surgeons guidance on the use of glucosamine/chondroitin sulfate supplements for joint health. The panel will focus specifically on the most recent AAOS Evidence-based Guideline for using joint health supplements and provide its recommendation based on a growing body of clinical evidence. 
 
"The very positive results from recent trials of glucosamine and chondroitin sulfate support our published research from 1999 and 2000," stated Robert Henderson, chairman Nutramax Laboratories. "In light of those results, it is time to start a dialog with the AAOS to review the accumulated clinical evidence regarding the combined use of glucosamine and chondroitin sulfate for joint health."  
 
Recently published randomized, controlled trials using high-quality, pharmaceutical-grade glucosamine and chondroitin sulfate, at a daily dose of 1,500 and 1,200 milligrams, respectively, have produced very positive outcomes for patient populations in the studies.
 
Under the guidance of Brian Cornblatt, medical director of Nutramax Laboratories, the panel of experts will review the available clinical evidence supporting the use of glucosamine/chondroitin sulfate supplementation in promoting joint health, and work with the AAOS guideline committee to explore consideration of this evidence in the third edition of the Evidence-based Guideline. The members of the task force will focus special attention on the following recent publications:
 
  • MOVES (Multicentre Osteoarthritis InterVEntion trial with Sysadoa): This study provides the most recent evidence to support the use of glucosamine hydrochloride and chondroitin sulfate, at a daily dose of 1,500 and 1,200 milligrams, respectively, in managing joint health in a wide variety of patient populations. The results were published in January 2015 in the online edition of Annals of the Rheumatic Diseases;
  • GAIT (Glucosamine/Chondroitin Arthritis Intervention Trial): Published in The New England Journal of Medicine in 2006, the GAIT study showed that glucosamine hydrochloride and chondroitin sulfate, at the same daily dose as used in the MOVES trial, may be a viable option in a subgroup of patients with moderate to severe joint discomfort. The MOVES study was developed as an extension of the GAIT study;
  • Brazilian Trial (Prospective, Multi-Center, Randomized Controlled Trial): In an international, head-to-head study involving more than 900 participants, a team of Brazilian researchers found that Nutramax Laboratories' CosaminDS, which contains 1,500 mg of glucosamine hydrochloride and 1,200 mg of chondroitin sulfate in capsule form, and a Brazilian prescription brand containing the same doses of these ingredients either as a sachet or a capsule formulation, were equally effective. The researchers, who published their results in Clinical Rheumatology in August 2014, reported statistically significant improvements in joint comfort and physical function as measured by change from baseline using a visual analog scale and the Lequesne Index, a measure of osteoarthritis severity. They also observed no significant alterations in laboratory values assessing safety, including fasting glycemia; and
  • Cochrane Review: In a review published in January 2015, the Cochrane Collaborative characterized chondroitin sulfate as more effective than placebo in improving pain and physical function in patients with osteoarthritis, with a lower risk of adverse events. The Cochrane review – the most comprehensive review of chondroitin sulfate published to date – examined data from 43 randomized, controlled, short-term trials involving 4,962 participants treated with chondroitin sulfate and 4,148 participants who were given a placebo or another control, and concluded that the benefit of chondroitin sulfate in these studies was clinically meaningful.
 
"Our aim is to explore whether current guidelines accurately reflect real-world experience and recent clinical evidence supporting the use of high-quality glucosamine and chondroitin to support joint health," said Nicholas DiNubile, an orthopedic surgeon. "It is important that we open discussions with our colleagues about the role of supplements and to achieve a better understanding of when and where high-quality supplements fit into the overall joint health management paradigm."
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Durex synchs app launch to Earth Hour

BY DSN STAFF

 

 
 
PARSIPPANY, N.J. — Durex on Monday revealed today the final chapter of its 'Durex Connect' campaign by releasing a smartphone app that helps people do exactly that, just in time for Earth Hour.
 
After teasing a technology breakthrough that could revolutionize our sex lives, a viral video (above) was released by Durex that quickly grew to be viewed by over 40 million people around the world. The video showed tech-obsessed couples' reactions to the revelation that the bedroom miracle they needed was simply the off-button. Following this international response, Durex developed an app that offers a simple solution: synchronizing a couple's phones to sleep together.
 
"The 'Durex Connect' film followed the couples who volunteered on an emotional and reflective journey where they came to terms with their true obsession with technology in their relationships, and the campaign has really highlighted this on a global scale," said Ukonwa Ojo, head of global brand equity at Durex. "The large number of people visiting the Durexlabs sign-up page really helped us truly understand the app needs of our consumers. As we approach Earth Hour on March 28 from 8:30 p.m. – 9:30 p.m., we invite couples around the world to discover this new Durex app."
 
The 'Durex Connect' app, available for free download on Android and soon to be out on iOS, is a user-friendly way to synchronize a smartphone with a person's partner, so that neither can renege on the promise of dedicated, tech-free connection. At agreed times, or by spontaneous agreement, it will simply mask the phones' home screen, effectively putting the handsets to sleep and removing all distractions.
 
 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?